Transient Treatment Exclusively Containing Nucleoside Analogue Reverse Transcriptase Inhibitors in Highly Antiretroviral-Experienced Patients Preserves Viral Benefit When a Fully Active Therapy Was Initiated-Reference-Cited by-同舟云学术

Transient Treatment Exclusively Containing Nucleoside Analogue Reverse Transcriptase Inhibitors in Highly Antiretroviral-Experienced Patients Preserves Viral Benefit When a Fully Active Therapy Was Initiated

Published:2008-12 Issue:6 Volume:9 Page:387-398
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Bonjoch A.,Buzon M.J.,Llibre J.M.,Negredo E.,Puig J.,Pérez-Alvarez N.,Videla S.,Martinez-Picado J.,Clotet B.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

http://www.tandfonline.com/doi/pdf/10.1310/hct0906-387

Reference20 articles.

1. Reassessing the goal of antiretroviral therapy in the heavily pre-treated HIV-infected patient

2. Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy

3. Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen

4. Long-Term Immunologic and Virologic Responses in Patients with Highly Resistant HIV Infection Who Are Treated with an Incompletely Suppressive Antiretroviral Regimen

5. Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable Viremia

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolution of clinical study design in heavily treatment-experienced persons with HIV: A critical review;Antiviral Therapy;2023-05-22

2. Antiretroviral resistance testing in HIV-positive people;Cochrane Database of Systematic Reviews;2018-11-09

3. Antiretroviral resistance testing in HIV-positive people;COCHRANE DB SYST REV;2018

4. HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury;International Journal of Hepatology;2012

5. Optimal Antiviral Switching to Minimize Resistance Risk in HIV Therapy;PLoS ONE;2011-11-03